Founded in April of 2004 by Anton-Lewis Usala, MD, CTMG is the only organization that provides comprehensive site management, utilizing cGMP-like process controls, formulated under Design Review procedures, and administered at our network Physician sites by CTMG clinical coordinators under our proprietary layered Quality Systems. CTMG uses the same systems all Sponsors utilize in bringing their discovery products into human studies with the same extensive documentation and validation systems. Dr. Usala noted that the only aspect of drug development that does not currently require design-reviewed cGMP-like processes administered under Quality Systems, is the clinical trial portion involving human patients. CTMG believes the lack of these systems results in the poor physician investigator clinical trial metrics, including significant delays.
